Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor

In recent years, the diagnosis and understanding of nonalcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), and its relationship with cardiovascular diseases (CVD) are gaining better understanding. As MASLD shares common risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Platek, Anna E., Szymanska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544058/
https://www.ncbi.nlm.nih.gov/pubmed/37790680
http://dx.doi.org/10.5114/ceh.2023.130744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544058/
https://www.ncbi.nlm.nih.gov/pubmed/37790680
http://dx.doi.org/10.5114/ceh.2023.130744

Ejemplares similares